Gastric cancer treatment guidelines in Japan

被引：570

作者：

Nakajima T. ^{[1
]}

机构：

[1] Cancer Institute Hospital, Toshima-ku, Tokyo 170-8455

来源：

Gastric Cancer | 2002年 / 5卷 / 1期

关键词：

EBM; Gastric cancer treatment guidelines; Stage-oriented treatment; Standard treatment;

D O I：

10.1007/s101200200000

中图分类号：

学科分类号：

摘要：

Recent developments in treatment modalities for gastric cancer have allowed the selection of a variety of treatments, and this has resulted in some confusion in daily practice. The Japan Gastric Cancer Association issued the first edition of Gastric cancer treatment guidelines in March, 2001 to provide a common basis of understanding of the extent of disease and selection of proper treatment among doctors, patients, and their families.

引用

页码：1 / 5

页数：4

共 24 条

[1] Gastric Cancer, 1, pp. 10-24, (1998)
[2] Nakajima T., Ohta K., Ohyama K., Tabular analysis of CIH (Cancer Institute Hospital) database, Multimodality therapy for gastric cancer, pp. 197-267, (1999)
[3] Hermans J., Bonenkamp H., In reply to the editor, J Clin Oncol, 12, pp. 879-880, (1994)
[4] Nakajima T., Ohta K., Ohyama S., Hamajima N., Meta-analysis of adjuvant chemotherapy trials for gastric cancer at the Cancer Institute Hospital, Tokyo, Multimodality therapy for gastric cancer, pp. 27-31, (1999)
[5] Earle C.C., Maroun J.A., Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomized trials, Eur J Cancer, 35, pp. 1059-1064, (1999)
[6] Krook J.E., O'Connel M.J., Wieand H.S., Beard R.W. Jr., Leigh J.E., Kugler J.W., Et al., A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer, Cancer, 67, pp. 2454-2458, (1991)
[7] Muggia F., How to improve survival after diagnosis of gastric cancer? It's back to the drawing board, J Clin Oncol, 11, pp. 1437-1438, (1993)
[8] Nakajima T., Review of adjuvant chemotherapy for gastric cancer, World J Surg, 19, pp. 570-574, (1995)
[9] Lise M., Nitti D., Marchet A., Sahmoud T., Buyse M., Duez N., Et al., Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer, J Clin Oncol, 33, pp. 2757-2763, (1995)
[10] Tsavaris N., Tentas K., Kosmidis P., Mylonakis N., Sakelaropoulos N., Kosmas C., Et al., A randomized trial comparing adjuvant fluorouracil, epirubicin and mitomycin with no treatment in operable gastric cancer, Chemotherapy, 42, pp. 220-226, (1996)

← 1 2 3 →